Vanessa Zanoni

Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer

Giovanni Allevi, Carla Strina, Daniele Andreis et al. · British Journal of Cancer · 2013 · 86 citations · Full text

Medicine, Oncology, Pharmacology +17

Triple Negative Breast Cancers Have a Reduced Expression of DNA Repair Genes

Enilze Maria de Souza Fonseca Ribeiro, Monica Ganzinelli, Daniele Andreis et al. · PLoS ONE · 2013 · 45 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer

Letizia Bazzola, Chiara Foroni, Daniele Andreis et al. · British Journal of Cancer · 2014 · 30 citations · Full text

Medicine, Oncology, Pharmacology +16

Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the “biological window therapy”

Chiara Foroni, M. Milan, Carla Strina et al. · Breast Cancer Research and Treatment · 2014 · 14 citations

Medicine, Oncology, Pharmacology +16